GLENMEDE TRUST CO NA - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,109,781
-0.6%
343,188
-0.9%
0.08%0.0%
Q2 2023$13,187,158
-0.1%
346,456
+0.2%
0.08%0.0%
Q1 2023$13,205,987
-32.2%
345,797
+1.1%
0.08%
-34.2%
Q4 2022$19,471,179
+28.1%
342,200
-11.0%
0.11%
+18.8%
Q3 2022$15,205,000
-19.9%
384,599
-10.8%
0.10%
-13.5%
Q2 2022$18,971,000
-0.6%
431,185
-9.9%
0.11%
+18.1%
Q1 2022$19,079,000
+317883.3%
478,428
+198417.8%
0.09%
Q3 2020$6,000
+100.0%
241
+61.7%
0.00%
Q2 2020$3,0000.0%149
-25.5%
0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,000
+50.0%
2000.0%0.00%
Q4 2018$2,000
-83.3%
200
-68.5%
0.00%
Q1 2018$12,0000.0%6350.0%0.00%
Q4 2017$12,000
+1100.0%
635
+267.1%
0.00%
Q2 2016$1,0000.0%1730.0%0.00%
Q1 2016$1,000
-80.0%
173
-68.1%
0.00%
Q2 2014$5,000
-44.4%
543
-26.9%
0.00%
Q1 2014$9,000
+12.5%
743
+36.8%
0.00%
Q4 2013$8,0005430.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders